PHILADELPHIA – Gemelli Biotech, in cooperation with the Medically Associated Science and Technology Program at Cedars-Sinai, announced the availability of ibs-smart, a blood test for the diagnosis of ...

She's an irritating, yet oddly captivating, redhead in a flesh-colored unitard with screen-printed intestines on her stomach. No, it's not your crazy cousin's latest Halloween getup, but the newest ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Ironwood Pharmaceuticals today announced ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today an agreement with Allergan plc for the U.S. co-promotion of VIBERZI™ (eluxadoline), Allergan’s new ...

IRVINE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced plans to launch its InFoods ® IBS test before calendar year end. The test will be ...

Biomerica Inc. has appointed Scott Madel as Chief Commercial Officer, bringing over 20 years of experience in revenue growth and commercialization in the healthcare and diagnostics sectors. Madel ...

Bioamerica has hired Robert Carlson as its new chief commercial officer as it prepares to launch the new InFoods IBS test before the end of the year. The test is currently in clinical trials at ...

Rifaximin (Xifaxan) is approved for the treatment of adults with irritable bowel syndrome plus diarrhea (IBS-D) and has demonstrated efficacy versus placebo for the improvement of abdominal and bowel ...

IBS-D is a subtype of IBS characterized by diarrhea. The triggers can vary among different people, but knowing finding out your potential triggers can help improve your daily life. Lifestyle ...

Habba syndrome is a term created by Dr. Saad F. Habba. It’s based on the theory that functional diarrhea and diarrhea-predominant IBS (IBS-D) are umbrella terms for other medical conditions that can, ...

Irritable bowel syndrome (IBS) can be tough to live with. How tough? A 2015 survey from the American Gastroenterological Association found that 47% of people with IBS would give up their cell phone ...